News
Third-party coverage and milestones from companies across the Ollin Ventures portfolio.
1 article
Eradivir
Eradivir announced dosing of the first patient in a Phase 2 study evaluating EV25 in adults with naturally occurring influenza infection in Bangladesh, conducted in collaboration with icddr,b.
July 7, 2026
